Reynolds Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Reynolds Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$371K	Sell	5,800 -7,600	-57%	-$479K	0.64%	44
2015 Q4	$922K	Buy	13,400 +6,100	+84%	+$403K	1%	24
2015 Q3	$432K	Buy	7,300 +3,600	+97%	+$228K	0.54%	58
2015 Q2	$246K	Sell	3,700 -3,500	-49%	-$231K	0.24%	157
2015 Q1	$464K	Buy	7,200 +2,200	+44%	+$138K	0.4%	81
2014 Q4	$295K	Buy	+5,000	New	+$282K	0.25%	165
2013 Q3	–	Sell	-7,500	Closed	-$336K	–	425
2013 Q2	$336K	Buy	+7,500	New	+$326K	0.25%	151

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Reynolds Capital Management's BMY Position: Q1 2016 in Review

Reynolds Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 57% in Q1 2016, selling an estimated $479K and leaving 5,800 shares worth $371K. The position accounts for 0.64% of the portfolio, ranked #44.

Reynolds Capital Management first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. The position peaked at $922K in Q4 2015. 1,524 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Reynolds Capital Management held 5,800 shares of Bristol-Myers Squibb worth $371K as of Q1 2016.
Reynolds Capital Management sold 7,600 Bristol-Myers Squibb shares in Q1 2016, an estimated $479K.
Bristol-Myers Squibb made up 0.64% of Reynolds Capital Management's portfolio in Q1 2016, its #44 holding.
Reynolds Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
Reynolds Capital Management's Bristol-Myers Squibb position peaked at $922K in Q4 2015.
1,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.